Our integrated team of scientific, business and operational leaders has an outstanding track record of identifying and nurturing companies that are developing disruptive technologies. The team is targeting investments in battlefield medical concerns such as Wound Care, Burn Care, Brain & Spinal Cord Injury, Traumatic Injury,  Acute Pain Management, replacement of Opioids, and the utilization of Artificial Intelligence, all demonstrating breakthroughs in the treatment of disease and substantial advantages over currently marketed products.